| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.007 |